Oxygen Therapy for Retinal Ischemia

Withdrawn before enrolling · Phase 4

Conditions studied: Retinal Ischemia

In brief

The investigators will be using nocturnal normobaric hyperoxia therapy in patients with diagnoses of conditions related to retinal ischemia.

Key facts

Study ID

NCT03730779

Run by

Beth Israel Deaconess Medical Center

People needed

0

Starts

2018-11-30

Expected to finish

2020-01-01

Last updated by the study team

2020-03-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of retinal-ischemia related condition

You may not qualify if…

• Complicating other ocular condition
• History of smoking or lung conditions

Where it is running

• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.